PetMed Express Inc PETS
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
News
PetMeds Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
PetMeds Enhances Board of Directors with Appointment of Tamar Elkeles as New Independent Director
PetMeds Appoints Jeff Willard as CEO & President and Announces Board Leadership Transition
PetMeds Appoints Andrew Parry as Chief Technology Officer
PetMeds® Announces First Quarter Financial Results
Trading Information
- Previous Close Price
- $1.24
- Day Range
- $1.19–1.23
- 52-Week Range
- $1.15–4.10
- Bid/Ask
- $1.19 / $1.25
- Shares Outstanding
- 21.68M
- Market Cap
- $26.45M
- Volume/Avg
- 29,575 / 107,979
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 0.15
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- —
Company Profile
PetMed Express Inc is a nationwide direct-to-consumer pet pharmacy and online provider of prescription and non-prescription medications, foods, supplements, supplies, and vet services for dogs, cats, and horses. It markets and sells directly to consumers through its websites, toll-free numbers, and mobile application, offering convenience, price, speed of delivery, and customer service. It provides access to branded pharmaceuticals, generic medications, compounded prescription medications, over-the-counter health and wellness products, prescription and non-prescription food, pharmacy fulfillment, and AutoShip capabilities. Its digital platform offers pet healthcare solutions for chronic conditions, including allergies, arthritis, anxiety, kidney-related conditions, and hyperthyroidism.
- Sector
- Healthcare
- Industry
- Pharmaceutical Retailers
- Stock Style Box
- Small Value
- Total Number of Employees
- 189
- Website
- https://www.petmeds.com
Valuation
Metric | PETS |
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | 1.15 |
Price/Sales | 0.15 |
Price/Cash Flow | — |
Price/Earnings
PETS
Financial Strength
Metric | PETS |
|---|---|
Quick Ratio | 0.36 |
Current Ratio | 0.68 |
Interest Coverage | — |
Quick Ratio
PETS
Profitability
Metric | PETS |
|---|---|
Return on Assets (Normalized) | −29.59% |
Return on Equity (Normalized) | −73.13% |
Return on Invested Capital (Normalized) | −72.82% |
Return on Assets
PETS
Pharmaceutical Retailers Industry Comparables
1-Day Chart | Name | Price | Morningstar Rating for Stocks | Capital Allocation | Economic Moat | Market Cap |
|---|---|---|---|---|---|---|
| JD Health International Inc JDHIF | — | LOCK|n!<P | $18B | |||
| JD Health International Inc ADR JDHIY | — | LOCK|!M#W | $18B | |||
| Alibaba Health Information Technology Ltd ALBHF | — | LOCK|<C%& | $6B | |||
| Alibaba Health Information Technology Ltd ADR ALBBY | — | LOCK|L!KYb | $6B | |||
| Raia Drogasil SA ADR RADLY | — | LOCK|^gt& | $5B | |||
| COSMOS Pharmaceutical Corp CSMYF | — | LOCK|nCQ | $3B | |||
| Sugi Holdings Co Ltd SGIPF | — | LOCK|S#G | $3B | |||
| Clicks Group Ltd CCKRF | — | LOCK|PlwbX | $3B | |||
| Clicks Group Ltd ADR CLCGY | — | LOCK|Wl?SY | $3B | |||
| Redcare Pharmacy NV ADR SAEYY | — | LOCK|YG | $2B |
United States